Anticancer agent 180
Anticancer agent 180 (compound 4) is a secondary metabolite induced by co-culture of fungi and actinomycetes, the later one can produce HDAC inhibitors Trichostatins. Anticancer agent 180 has potential anti-tumor activity and can inhibit the migration of MDA-MB-231 breast cancer cells[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-180.html
Solubility
10 mM in DMSO
Smiles
OC(C(C1=CC=C(C=C1)O)=CN(C)C2=O)=C2[C@@]3([H])O[C@](CCC(CC(CC)C)C)([H])CCC3
Molecular Formula
C26H37NO4
Molecular Weight
427.58
References & Citations
[1]Hwang GJ, et al. Induction of Fungal Secondary Metabolites by Co-Culture with Actinomycete Producing HDAC Inhibitor Trichostatins. J Microbiol Biotechnol. 2023 Nov 28;33 (11) :1437-1447.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
